Skip to main content


During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
641 of 1850

Newsletter Sign Up

Daily Readings

Reading 1, Jonah 3:1-10
The word of Yahweh was addressed to Jonah a second time. 'Up!' ... Read More

Psalm, Psalms 130:1-2, 3-4, 7-8
[Song of Ascents] From the depths I call to you, Yahweh: Lord, ... Read More

Gospel, Luke 10:38-42
In the course of their journey he came to a village, and a ... Read More

Saint of the Day

October 6 Saint of the Day

St. Bruno
October 6: Bruno was born in Cologne of the prominent Hartenfaust family. ... Read More